Journal of Histochemistry and Cytochemistry, Vol. 49, 313-322, March 2001, Copyright © 2001, The Histochemical Society, Inc.


ARTICLE

Immunohistochemical Localization of Laminin and Fibronectin Isoforms in Human Placental Villi

Matti Korhonena,b and Ismo Virtanenb
a Helsinki University Central Hospital, Hospital for Children and Adolescents, Helsinki, Finland
b Department of Anatomy, Institute of Biomedicine, University of Helsinki, Helsinki, Finland

Correspondence to: Matti Korhonen, Hospital for Children and Adolescents, Helsinki University Central Hospital, FIN-00290 Helsinki, Finland. E-mail: matti.korhonen@helsinki.fi


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

We studied the localization of laminin {alpha}1, {alpha}2, {alpha}3, {alpha}5, {beta}1, {beta}2, and {gamma}1 chains and extradomain A- (EDA), EDB-, and oncofetal fibronectin by immunohistochemistry in human placental villi during placental development. The laminin {alpha}2, {alpha}5, {beta}1, {beta}2, and {gamma}1 chains were detected in the trophoblastic basement membrane (BM) at all stages of gestation, suggesting the presence of laminin-2, -4, -10, and -11 trimers. The laminin {alpha}1 chain was selectively found at sites where the villous BM was in contact with proliferating cells in trophoblastic islands or columns. EDA-Fn, but not other Fn isoforms, was found in the trophoblastic BM during the first trimester. The laminin {alpha}2, {beta}1, {beta}2, and {gamma}1 chains were detected in the villous stroma and capillaries throughout placental development, while the laminin {alpha}5 chain emerged distinctly during development. Extensive EDA-Fn immunoreactivity was found in first-trimester villous stroma, but distinctly fewer Fn isoforms were seen in the villous stroma during the later stages of gestation. Our results also suggest that, during the formation of new villi, laminins are not found in trophoblastic sprouts before the ingrowth of the villous mesenchyme. Rather, laminins may be deposited at the villous epithelial–mesenchymal interface. Furthermore, the results show that distinct changes occur in the localization of various laminin and Fn isoforms during the maturation of villous trophoblastic and capillary BMs. (J Histochem Cytochem 49:313–322, 2001)

Key Words: placenta, laminin, fibronectin, basement membrane, extracellular matrix proteins, immunohistochemistry, human


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Basement membranes (BMs) are specialized extracellular matrices found subjacent to epithelial sheets. In addition to contributing to the structural organization of epithelial tissue, BMs are essential to the development and maintenance of epithelial cell differentiation (Aumailley and Smyth 1998 ; Ekblom et al. 1998 ).

Laminins are important constituents of BMs. Since the first isolation of laminin-1 from a murine tumor (Timpl et al. 1979 ), it has become evident that laminins comprise a family of related molecules. Laminins are heterotrimeric glycoproteins consisting of an {alpha}-, {beta}-, and a {gamma}-type chain, where different chain isoforms may form heterotrimers rather promiscuously (Aumailley and Smyth 1998 ; Colognato and Yurchenko 2000 ). Localization studies using chain-specific antibodies on various tissues have demonstrated that there are organ- and even cell type-specific differences in laminin isoform distribution, reflecting the heterogeneity of BMs (Virtanen et al. 1997 , Virtanen et al. 2000 ; Ekblom et al. 1998 ).

Fibronectin is a ubiquitous component of the extracellular matrix (ECM). Fibronectin is found as an intrinsic component in some BMs during development (Laitinen et al. 1991 ), but it is lacking in most developing and mature BMs. Isoforms containing the extradomain A (EDA) and EDB are produced by alternative splicing of mRNA (Ffrench-Constant 1995 ). Furthermore, alternative glycosylation within the CSIII domain creates an immunologically defined epitope, oncofetal fibronectin, which is often found in developing and malignant tissues (Matsuura and Hakomori 1985 ).

Earlier, we have studied the distribution of integrins and ECM molecules in the developing and term human placenta (Virtanen et al. 1988 ; Korhonen et al. 1991 ; Korhonen and Virtanen 1997 ). In this work we have extended these studies to the distribution of the various laminin and fibronectin isoforms in human placental villi.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Tissues
Sixteen human placentas (seven 8–10 weeks, five 12–20 weeks, and four 38–40 weeks of gestation) were aquired from spontaneous abortions due to rupture of fetal membranes, from legal abortions performed for psychosocial indications, or from normal deliveries at the Jorvi Hospital, Espoo, Finland. The tissues were frozen in liquid nitrogen and stored at -70C until use.

Antibodies
The following MAbs and antisera to laminin and fibronectin isoforms were used in the study: {alpha}1 (clone EB7, Virtanen et al. 2000 ), {alpha}2 (clone 5H2, Leivo and Engvall 1988 ), {alpha}3 (clone BM-2, Rousselle et al. 1991 ), {alpha}5 (clone 4C7, Engvall et al. 1986 ; Tiger et al. 1997 ) {beta}1 (clone 4E10, Wewer et al. 1983 ; Engvall et al. 1990 ; LnB1, Virtanen et al. 1997 ), {beta}2 (clone C4, Hunter et al. 1989 ), {beta}3 (clone 6F12, Marinkovich et al. 1992 ), {gamma}1 (clone 2E8, Engvall et al. 1986 , Engvall et al. 1990 ), 1141 (a rabbit antiserum to EHS laminin; Liesi et al. 1983 ), fibronectin (clone 52BF12 recognizing all fibronectins; Vartio et al. 1987 ); EDA-fibronectin (EDA-Fn, clone 52DH1; Vartio et al. 1987 ); EDB-fibronectin (EDB-Fn, clone BC-1 recognizing a neoepitope found in fibronectin that contains the EDB; Carnemolla et al. 1992 ), and Onc-fibronectin (Onc-Fn, clone FDC-6; Matsuura and Hakomori 1985 ). Anti-cytokeratin 19 serum (Leoncini et al. 1990 ) was used to identify trophoblastic cells in double immunostainings and serial sections. Polyclonal antisera to desmin (Virtanen et al. 1986 ) and vimentin (Virtanen et al. 1981 ) were used to identify the villous stroma, and capillaries were localized using Ulex europaeus agglutinin (UEA-I; Vector Laboratories, San Mateo, CA; Holthofer et al. 1982 ). The optimal dilutions of the antibodies and lectins were determined by using a panel of human normal tissues.

Immunohistochemistry and Microscopy
Five-µm frozen sections were fixed in acetone at -20C for 10 min. For indirect immunofluorescence microscopy, the sections were incubated with the primary antibody and subsequently with the secondary antibodies (fluorescein isothiocyanate–coupled goat anti-mouse IgG and tetramethylrhodamine-coupled goat anti-rabbit IgG sera; Jackson Immunoresearch, West Grove, CA) at room temperature for 30 min. Negative controls, in which sections were exposed only to the secondary antisera, did not display unspecific immunoreactivity. The specimens were embedded in sodium-veronal/glycerol buffer (1:1; pH 8.4), or Mowiol in the case of lectins, and were examined with a Leitz Aristoplan microscope equipped with appropriate filters.

The distribution of the various laminin and fibronectin chains was evaluated by indirect immunofluorescence from sets of serial sections of the placental samples. Histology of the immunofluorescence sections was evaluated by light microscopy of hematoxylin–eosin-stained adjacent sections. The nomenclature for placental structures has been adapted from Benirschke and Kaufmann 1990 and Castellucci et al. 1990 . It has been shown by three-dimensional reconstructions from serial sections that "syncytial knots," "sprouts," and "bridges" are often mere tangential sections of tortuous villous surfaces (Cantle et al. 1987 ). Our observations in this study support this interpretation. To ensure that the trophoblastic sprouts were indeed genuine sprouts, the histology of individual sprouts was followed from at least six serial 5-µm sections covering a depth of 30 µm.


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

The results are summarized in Table 1. For each aspect mentioned in the table, sections from at least three placental tissue blocks were studied. The immunofluorescence results on different tissue samples were consistent, with no major variations in fluorescence intensity or distribution.


 
View this table:
[in this window]
[in a new window]
 
Table 1. Distribution of laminins and fibronectins in placental villia

The Villous Trophoblastic BM
Antibodies detecting laminin {beta}1 (Fig 1a and Fig 1b), {alpha}5 (Fig 1c), and {alpha}2 (Fig 1d) chains reacted avidly in a linear pattern at the periphery of placental villi of all three trimesters. Double immunostainings using the anti-cytokeratin serum (Fig 1a and Fig 1b), identifying the trophoblast, indicated that these laminin chains were found at the basal aspect of the villous trophoblast, apparently in trophoblastic BMs. Furthermore, a weaker but convincing BM-like immunoreactivity for {beta}2 (Fig 1e) and {gamma}1 (Fig 1f) chains was detected basally to the villous trophoblast. No distinct differences were noted in the distribution of laminin chain immunoreactivities in trophoblastic BMs from placentas at various stages of gestation.



View larger version (136K):
[in this window]
[in a new window]
 
Figure 1. Laminin chains in placental villi. (a,b) Immunoreactivity for the laminin {beta}1 chain is found in the trophoblastic (large arrows) and capillary (small arrows) BMs and in the stroma in first trimester placenta. (b) Double immunostaining using anti-cytokeratin 19 serum, showing that the {beta}1 chain antibody reacts in a linear pattern at the basal aspect of the villous trophoblastic cells. Arrowheads (a,b) show the apical aspect of the trophoblastic cells. Bars = 40 µm. (c,d) Anti-{alpha}5 chain (c) and anti-{alpha}2 chain (d) MAbs react prominently with villous trophoblastic (large arrows) and capillary (small arrows) BMs, and also with villous stroma in third-trimester placental villi. Bars = 20 µm. Anti-{beta}2 chain (e) and anti-{gamma}1 chain (f) MAbs react with villous trophoblastic (large arrows) and capillary (small arrows) BMs and the villous stroma. Bars = 40 µm.

Interestingly, distinct immunoreactivity for the laminin {alpha}1 chain was localized selectively in trophoblastic BMs at sites of formation of extravillous trophoblast. In first-trimester placentas, when extravillous trophoblast is typically found in trophoblastic cell islands, immunoreactivity for the laminin {alpha}1 chain was detected in the trophoblastic BM that is in direct contact with extravillous trophoblastic cells (Fig 2a and Fig 2b). The rest of the villous trophoblastic BM was negative. In second-trimester placentas, extravillous trophoblast often forms anchoring trophoblastic cell columns. Analogously to first, trimester placentas, the laminin {alpha}1 chain MAb reacted avidly with the trophoblastic BM at these sites (Fig 2c–2f), whereas reactivity was not detected in BMs in other parts of villi. No immunoreactivity for the laminin {alpha}1 chain was found among the extravillous trophoblastic cells themselves within cell islands or columns. In third-trimester placentas, additional weak and irregular laminin {alpha}1 immunoreactivity was detected in the trophoblastic BM of large stem villi (not shown).



View larger version (109K):
[in this window]
[in a new window]
 
Figure 2. Laminin {alpha}1 chain in placenta. (a,b) Immunoreactivity for the laminin {alpha}1 chain in a 10-week placenta (a) is seen selectively in the trophoblastic BM (small arrows) adjacent to a trophoblastic cell island, revealed by double immunostaining by antiserum to cytokeratin 19 (b). The rest of the trophoblastic BM (large arrows) is negative. (c,d) The laminin {alpha}1 chain MAb (c) reacts in a 16-week placenta with a defined portion of the trophoblastic BM (small arrows), while the rest of the villous BM (large arrows), revealed by double immunostaining with antiserum to EHS-laminin (d), does not react. (e,f) In an adjacent section, the laminin {alpha}1 chain MAb (e) reacts selectively with the trophoblastic BM (small arrows) in contact with a trophoblastic column from which extravillous trophoblastic cells, revealed by double immunostaining with anti-cytokeratin 19 serum (f), invade the decidua. The trophoblastic BM under villous trophoblast (large arrows) lacks {alpha}1 immunoreactivity. Bars = 50 µm.

The fibronectin and EDA–fibronectin (Fig 3a) MAbs revealed linear immunoreactivity in the trophoblastic BMs of first-trimester placentas. However, these antigens were not predominantly detected in second- (Fig 3b) and third-trimester villous trophoblastic BMs. The EDB–fibronectin (Fig 3c and Fig 3d) and oncofetal fibronectin (not shown) MAbs did not react with villous trophoblastic BMs.



View larger version (79K):
[in this window]
[in a new window]
 
Figure 3. Fibronectins in placenta. (a,b) The MAb to EDA–fibronectin reacted in a linear pattern with the villous trophoblastic BM in first- (large arrows in a) but not second (large arrows in b)-trimester placentas. The MAb reacted with villous stroma and capillary BMs (small arrows). (c,d) The MAb to EDB–fibronectin (c) reacted distinctly with villous capillary (small arrows) but not trophoblastic (large arrows) BMs in first-trimester placentas. (d) Double immunostaining with anti-cytokeratin 19 serum of the section in c, revealing the location of the villous trophoblast. Bars = 40 µm.

Villous Stroma and Capillaries
In addition to immunoreactivity in trophoblastic BMs, distinct immunoreactivity for laminin {alpha}2 (Fig 1d) and {beta}1 (Fig 1a) chains was found in villous stroma and capillaries. The laminin {beta}2 (Fig 1e) and {gamma}1 (Fig 1f) chain MAbs also reacted weakly with these structures. In contrast to the {alpha}2-, {alpha}1-, {beta}2-, and {gamma}1 chain MAbs, laminin {alpha}5 chain antibodies failed to react with the villous stroma and capillaries (Fig 4a–4d) of first-trimester placentas. However, intense immunoreactivity for the laminin {alpha}5 chain was detected in BMs of villous capillaries in third-trimester placentas (Fig 1c).



View larger version (73K):
[in this window]
[in a new window]
 
Figure 4. Laminin {alpha}5 chain in first-trimester placental villi. (a,b) Whereas laminin {alpha}615 chain MAb reacts only with the trophoblastic BM (a), double immunostaining with EHS–laminin antiserum (b) reveals both the villous trophoblastic BM (large arrows) as well as stromal elements. (c,d) Double staining using laminin {alpha}1 MAb (c) and UEA-I (d) revealing villous capillaries, demonstrating that first-trimester placental villous capillaries are not immunoreactive for the laminin {alpha}5 chain. Bars = 50 µm.

The MAbs recognizing fibronectin and EDA–fibronectin revealed distinct, spotty immunoreactivity in first-trimester villous stromal tissue and reacted with villous capillaries (Fig 3a). The EDB–fibronectin (Fig 3c and Fig 3d) and oncofetal fibronectin MAbs reacted similarly but more weakly. In second- and third-trimester placentas, the anti-EDA–fibronectin MAb (Fig 3b) reacted weakly with the villous stroma and distinctly with capillaries, while weak immunoreactivity for EDB– and oncofetal fibronectin was seen in villous capillaries (not shown).

Trophoblastic Sprouts
Trophoblastic sprouts are outgrowths from the surfaces of existing villi, believed to represent sites of formation of new ones. The presence of laminin isoforms in the sprouts was determined from serial sections of first-trimester placentas. The trophoblastic sprouts were devoid of laminin and fibronectin chain immunoreactivity, as assayed by the MAbs (Fig 5a–5d) as well as the EHS–laminin antiserum (Fig 5e). However, when a mesenchymal core, identified by double immu-nostaining with desmin (Fig 5c) or vimentin (not shown), was present in the sprouts defining them as villous sprouts, distinct immunoreactivity for the laminin {alpha}5, {alpha}2, {beta}1 (Fig 5a), and weaker for {beta}2 and {gamma}1 (Fig 5d) chains was detected in the sprouts at the trophoblast–mesenchyme interphase and in the mesenchymal core.



View larger version (100K):
[in this window]
[in a new window]
 
Figure 5. Laminin chains in sprouting villi. (a–c) Villous sprout that continues as a trophoblastic sprout from first-trimester placenta. The anti-{beta}1 chain MAb (a) reacts at the trophoblastic–mesenchymal interphase (arrows), but immunoreactivity does not extend into the trophoblastic sprout (arrowheads), revealed by double immunostaining with anti-cytokeratin 19 serum (b). (c) serial section to a,b, stained with desmin antiserum, showing that the mesenchyme indeed does not extend into the trophoblastic sprout (arrowheads). (d,e) Double immu-nostaining of a villous sprout that continues as a trophoblastic sprout using anti-{gamma}1 chain MAb (d) and EHS-laminin antiserum (e). Note that both immunoreactivities extend to the very tip of the villous sprout (arrow) but are not found in the trophoblastic sprout (arrowhead). (f) Third-trimester placental villi do not react with MAb to the laminin {alpha}3 chain. Bars = 40 µm.

We also asked whether the BM at the tip of the mesenchymal villous core ingrowth into the trophoblastic villus, which may represent a site of formation of nascent BM, differs in laminin composition from the rest of the trophoblastic BM. The distributions of the immunoreactions of each laminin chain at these locations were found to be identical with that of the polyclonal EHS–laminin antiserum (Fig 5d and Fig 5e). This indicates that all laminin chains are found at the tip of the mesenchymal villous core ingrowth into the trophoblastic villus.

No immunoreactivity for the the {alpha}3 (Fig 5f) and {beta}3 laminin chains was detected in placental villous BM or stroma at any gestational age.


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

The placenta and cells derived therefrom have been a major source of human laminins for biochemical studies. Earlier studies have shown that laminin is found in BMs of placental villi as well as decidual cells (Charpin et al. 1985 ; Kurosawa et al. 1985 ; Yamada et al. 1987 ; Earl et al. 1990 ; Graf et al. 1997 ). Leivo et al. 1989 reported that the {alpha}2 chain is found in trophoblastic BMs. Likewise, it has been reported that fibronectin (Kurosawa et al. 1985 ; Yamaguchi et al. 1985 ; Yamada et al. 1987 ) and EDA–fibronectin (Virtanen et al. 1988 ) are found in the trophoblastic BM and villous mesenchyme and capillaries during the first trimester, but are confined to villous capillaries later during placental development. However, these studies were carried out using polyclonal antibodies or a single monoclonal antibody that detects one laminin or fibronectin chain. Therefore, it is of interest to develop a comprehensive view of the localization of laminin and fibronectin isoforms within the developing and mature human placenta.

Antibodies
The specificity of the antibodies used in our study requires comment. The MAb C4 (anti-laminin {beta}2) has been reported to crossreact weakly with the laminin {beta}1 chain and with an unidentified high molecular weight band in rat tissue extracts (Hunter et al. 1989 ; Sanes et al. 1990 ). We have shown, however, that the MAb C4 is specific for the laminin {beta}2 chain in human placental tissue (Korhonen and Virtanen 1997 ).

The MAb 4C7, formerly believed to recognize the laminin {alpha}1 chain, has been shown to recognize laminin {alpha}5 (Tiger et al. 1997 ; Church and Aplin 1998 ). The terminology of earlier reports must be re-interpreted in this respect.

The Trophoblastic BM
In this work we demonstrate that the {alpha}2, {alpha}5, {beta}1, {beta}2, and {gamma}1 laminin chains are found in the villous trophoblastic BM as well as in the stroma. In agreement with these results, laminin-2, -4, -10, and -11 (Engvall et al. 1990 ; Brown et al. 1994 ) have been isolated from human placental tissue. Earlier reports have suggested that laminin {alpha}2 and {alpha}5 chains, as well as the {beta}1 and {beta}2 chains, have mutually exclusive distributions in BMs of various locations (Engvall et al. 1990 ; Sanes et al. 1990 ). In placental villi, this is clearly not the case. Immunoreactivity for all these four chains was found in trophoblastic and villous capillary BMs.

Interestingly, laminin {alpha}1 chain was found selectively in trophoblastic BMs adjacent to trophoblastic cell islands and columns. A similar restricted distribution has been described for tenascin (Castellucci et al. 1991 ). These structures are sites of active cell division (Korhonen and Virtanen 1997 ), and the ECM is an important regulator of cell proliferation and differentiation (Ekblom et al. 1998 ). However, the significance of the selective localization of laminin {alpha}1 chain at these sites is unknown at present. These results support the hypothesis that cell islands and columns are homologous structures (Benirschke and Kaufmann 1990 ). The data complement our earlier results (Korhonen and Virtanen 1997 ) on the distribution of ECM molecules among extravillous trophoblastic cells. It appears that among the various laminin chains, only the laminin {alpha}5, {alpha}1, and {gamma}1 chains are found both in the trophoblastic BM and within the matrix deposition zone of anchoring cell columns, whereas the {alpha}1, {alpha}2 and {beta}2 chains are confined to the trophoblastic BM. Durbeej et al. 1996 suggested that {alpha}1 and {beta}2 chains would have mutually exclusive localizations. At these sites, however, {alpha}1 and {beta}2 are co-expressed, possibly allowing the presence of laminin-3. Indeed, we have recently purified laminin-3 from human placental tissue (Champliaud et al. 2000 ).

Furthermore, the study shows that laminin {alpha}3 and {beta}3 chains are not found in placental tissue, suggesting that laminins-5, -6, and -7 are not present in placenta.

Earlier studies have shown that fibronectin is found in trophoblastic BMs during the first trimester but disappears later in development (Kurosawa et al. 1985 ; Yamaguchi et al. 1985 ; Yamada et al. 1987 ; Virtanen et al. 1988 ). Here we show that EDA–fibronectin is, and EDB– and oncofetal fibronectin are not, present in developing trophoblastic BMs.

Trophoblastic Sprouts
Autio-Harmainen et al. 1991 reported rich expression of laminin {beta}1 and collagen Type IV mRNA and proteins in "cytotrophoblastic columns," and hypothesized that the presence of these proteins is required for the ingrowth of the villous stroma during development of new villi. These results are somewhat contradictory to those presented in this study. In part, this is due to the general confusion of terminology in the field of placental histology. Villous trophoblastic sprouts are believed to represent sites of production of new villi from existing villi (Benirschke and Kaufmann 1990 ; Castellucci et al. 1990 ). By definition, they lack a mesenchymal core, and consist only of syncytio- or cytotrophoblasts. During villous development, these structures are invaded by mesenchyme and are then called villous sprouts. Our results demonstrate that laminin and fibronectin proteins are not present in pure trophoblastic sprouts but that, when mesenchymal elements invade their core, laminins and EDA–fibronectin are detected at the trophoblast–mesenchyme interface and within the mesenchymal core itself. These results imply that the prior presence of these ECM proteins may not be required for the ingrowth of the mesenchyme. Rather, it is likely that epithelial–mesenchymal interaction is a prerequisite for the deposition of these BM components.

We also asked whether there would be differences in the distribution of the individual laminin chains at the tip of the mesenchymal ingrowth into the developing villus. We hypothesized that a differential distribution would indicate that particular laminin trimers would be deposited in the maturing trophoblastic BM before other isoforms. However, all the {alpha}2, {alpha}5, {beta}1, {beta}2, and {gamma}1 laminin chains were distributed co-extensively at the tip of the mesenchymal core.

In contrast to trophoblastic sprouts, abundant ECM proteins are found among extravillous trophoblastic cells in trophoblastic columns and islands (Korhonen and Virtanen 1997 ). However, these are not sites of formation of new villi. We suggest that the structures alluded to by Autio-Harmainen et al. 1991 are formations of extravillous trophoblast.

Villous Stroma and Capillaries
Distinct changes in the distribution of laminin chains during the development of the villous capillaries were noted. Whereas laminin {alpha}2, {beta}1, {beta}2, and {gamma}1 chains, possibly as laminin-2 and laminin-4, were found in the capillary BMs throughout placental development, {alpha}5 was seen only in the BMs of second- and third-trimester villous capillaries. Both laminin {alpha}2 and {alpha}5 chains are also found in brain capillary BMs (Jucker et al. 1996 ). However, capillaries of the kidney, skeletal muscle, and heart are not immunoreactive for the laminin {alpha}2 chain (Leivo and Engvall 1988 ; Engvall et al. 1990 ; Sanes et al. 1990 ; Virtanen et al. 1995 ). It is clear that capillary BMs are heterogenous with respect to their laminin composition. Our results are in contradiction to those of Leivo and Engvall 1988 as well as these of Leivo et al. 1989 , who reported that laminin {alpha}2 chain is not found in BMs of villous capillaries. In the latter study, the anti-{alpha}2 chain MAb was the same as used in this study. Pepsin-digested, paraffin-embedded tissues were studied, whereas we used acetone-fixed frozen sections; this difference may account for the discrepancy.

EDB– and oncofetal fibronectin were found in capillaries in first- but not third-trimester placental villi, possibly reflecting their role in angiogenesis. Interestingly, EDB–fibronectin is specifically found in tumors and other pathological processes at sites of neovascularization (Tarli et al. 1999 ).

The results of this study show that several laminin and fibronectin isoforms are found in the villous trophoblastic and capillary BMs and in the villous stroma, and that the distribution of some of these ECM molecules is regulated during trophoblastic and capillary BM maturation. During outgrowth of new villous structures, laminins are not found in the trophoblastic sprouts, but they are deposited at the trophoblast–mesenchyme interface as the sprouts are invaded by mesenchyme. This suggests that epithelial–mesenchymal interaction is a prerequisite for the deposition of the villous BM components.


  Acknowledgments

Supported by a project grant from the Medical Faculty, University of Helsinki.

We are indebted to Drs R.E. Burgeson, E. Engvall, S.-I. Hakomori, P. Liesi, V. Pallini, J. Sanes, and L. Zardi for kind gifts of antibodies. The skillful technical assistance of Mr Hannu Kamppinen, Mr Reijo Karppinen, and Ms Marja-Leena Piironen is acknowledged.

Received for publication June 22, 2000; accepted October 10, 2000.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Aumailley M, Smyth N (1998) The role of laminins in basement membrane function. J Anat 193:1-21[Medline]

Autio–Harmainen H, Sandberg M, Pihlajaniemi T, Vuorio E (1991) Synthesis of laminin and type IV collagen by trophoblastic cells and fibroblastic stromal cells in the early human placenta. Lab Invest 64:483-491[Medline]

Benirschke K, Kaufmann P (1990) Pathology of the Human Placenta. New York, Springer-Verlag

Brown JC, Wiedemann H, Timpl R (1994) Protein binding and cell adhesion properties of two laminin isoforms (AmB1eB2e, AmB1sB2e) from human placenta. J Cell Sci 107:329-338[Abstract/Free Full Text]

Cantle SJ, Kaufman P, Luckhardt M, Schweikhart G (1987) Interpretation of syncytial sprouts and bridges in the human placenta. Placenta 8:221-234[Medline]

Carnemolla B, Leprini A, Allemanni G, Saginati M, Zardi L (1992) The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. J Biol Chem 267:24689-24692[Abstract/Free Full Text]

Castellucci M, Classen–Linke I, Muhlhauser J, Kaufmann P, Zardi L, Chiquet–Ehrismann R (1991) The human placenta: a model for tenascin expression. Histochemistry 95:449-458[Medline]

Castellucci M, Scheper M, Scheffen I, Celona A, Kaufmann P (1990) The development of the human placental villous tree. Anat Embryol 181:117-128[Medline]

Champliaud MF, Virtanen I, Tiger CF, Korhonen M, Burgeson R, Gullberg D (2000) Posttranslational modifications and beta/gamma chain associations of human laminin alpha1 and laminin alpha5 chains: purification of laminin-3 from placenta. Exp Cell Res 15:259:326–335

Charpin C, Kopp F, Pourreau–Schneider N, Lissitzky JC, Lavaut MN, Martin PM, Toga M (1985) Laminin distribution in human decidua and immature placenta. Am J Obstet Gynecol 151:822-826[Medline]

Church HJ, Aplin JD (1998) BeWo choriocarcinoma cells produce laminin 10. Biochem J 332:491-498[Medline]

Colognato H, Yurchenko PD (2000) Form and function: the laminin family of heterotrimers. Dev Dyn 218:213-234[Medline]

Durbeej M, Fecker L, Hjalt T, Zhang HY, Salmivirta K, Klein G, Timpl R, Sorokin L, Ebendal T, Ekblom P, Ekblom M (1996) Expression of laminin alpha 1, alpha 5 and beta 2 chains during embryogenesis of kidney vasculature. Matrix Biol 15:397-413[Medline]

Earl U, Estlin C, Bulmer JN (1990) Fibronectin and laminin in the early human placenta. Placenta 11:223-231[Medline]

Ekblom M, Falk M, Salmivirta K, Durbeej M, Ekblom P (1998) Laminin isoforms and epithelial development. Ann NY Acad Sci 857:194-211[Abstract/Free Full Text]

Engvall E, Davis GE, Dickerson K, Ruoslahti E, Varon S, Manthorpe M (1986) Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J Cell Biol 103:2457-2465[Abstract]

Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR (1990) Distribution and isolation of four laminin variants: tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1:731-740[Medline]

Ffrench-Constant C (1995) Alternative splicing of fibronectin—many different proteins but few different functions. Exp Cell Res 221:261-271[Medline]

Graf R, Matejevic D, Schuppan D, Neudeck H, Shakibaei M, Vetter K (1997) Molecular anatomy of the perivascular sheath in human placental stem villi: the contractile apparatus and its association to the extracellular matrix. Cell Tissue Res 290:601-607[Medline]

Holthöfer H, Virtanen I, Kariniemi A-L, Hormia M, Linder E, Miettinen A (1982) Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest 47:60-66[Medline]

Hunter DD, Shah V, Merlie JP, Sanes JR (1989) A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction. Nature 338:229-234[Medline]

Jucker M, Tian M, Norton DD, Sherman C, Kusiak JW (1996) Laminin alpha 2 is a component of brain capillary basement membrane: reduced expression in dystrophic dy mice. Neuroscience 71:1153-1161[Medline]

Korhonen M, Virtanen I (1997) The distribution of laminins and fibronectins is modulated during extravillous trophoblastic cell differentiation and decidual cell response to invasion in the human placenta. J Histochem Cytochem 45:569-583[Abstract/Free Full Text]

Korhonen M, Ylänne J, Laitinen L, Cooper HM, Quaranta V, Virtanen I (1991) Distribution of the {alpha}1-{alpha}6 integrin subunits in human developing and term placenta. Lab Invest 65:34-356

Kurosawa K, Isemura M, Yamaguchi Y, Yosizawa Z, Furuyama T, Yoshinaga K, Ishii T (1985) Changes in distribution of connective tissue components of human placentae with maturation. Tohoku J Exp Med 147:261-265[Medline]

Laitinen L, Vartio T, Virtanen L (1991) Cellular fibronectins are differentially expressed in human fetal and adult kidney. Lab Invest 64:492-498[Medline]

Leivo I, Engvall E (1988) Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 85:1544-1548[Abstract]

Leivo I, Laurila P, Wahlström T, Engvall E (1989) Expression of merosin, a tissue-specific basement membrane protein, in the intermediate trophoblast cells of choriocarcinoma and placenta. Lab Invest 60:783-790[Medline]

Leoncini P, Betracca R, Ruggiero P, Shintorino M, Syrjänen S, Mäntyjärvi R, Syrjänen K (1990) Expression of cytokeratin no. 19(polypeptide in genital papillimovirus lesions Gynecol Obstet Invest 29):59-66

Liesi P, Dahl D, Vaheri A (1983) Laminin is produced by early rat astrocytes in primary culture. J Cell Biol 96:920-924[Abstract]

Marinkovich MP, Lunstrum GP, Burgeson RE (1992) The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 267:17900-17906[Abstract/Free Full Text]

Matsuura H, Hakomori SI (1985) The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci USA 82:6517-6521[Abstract]

Rousselle P, Lunstrum GP, Keene DR, Burgeson RE (1991) Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 114:567-576[Abstract]

Sanes JR, Engvall E, Butkowski R, Hunter DD (1990) Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 111:1685-1699[Abstract]

Tarli L, Balza E, Viti F, Borsi L, Castellani P, Berndorff D, Dinkelborg L, Neri D, Zardi L (1999) A high-affinity human antibody that targets tumoral blood vessels. Blood 94:192-198[Abstract/Free Full Text]

Tiger CE, Champliaud MF, Pedrosa–Domello F, Thornell LE, Ekblom P, Gullberg D (1997) Presence of laminin {alpha}5 chain and lack of laminin {alpha}1 chain during human muscle development and in muscular dystrophies. J Biol Chem 272:28590-28595[Abstract/Free Full Text]

Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR (1979) Laminin—a glycoprotein from basement membranes. J Biol Chem 254:9933-9937[Abstract]

Vartio T, Laitinen L, Närvänen O, Cutolo M, Thornell L-E, Zardi L, Virtanen I (1987) Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 88:419-430[Abstract]

Virtanen I, Gullberg D, Rissanen J, Herva R, Kivilaakso E, Kiviluoto T, Laitinen LA, Lehto VP, Ekblom P (2000) Laminin {alpha}-1 chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. Exp Cell Res 257:298-309[Medline]

Virtanen I, Kallajoki M, Närvänen O, Paranko J, Thornell L-E, Miettinen M, Lehto V-P (1986) Peritubular myoid cells of human and rat testis are smooth muscle cells that contain desmin-type intermediate filaments. Anat Rec 215:10-20[Medline]

Virtanen I, Laitinen L, Korhonen M (1995) Differential expression of laminin polypeptides in developing and adult human kidney J Histochem Cytochem 43:621-628

Virtanen I, Laitinen L, Vartio T (1988) Differential expression of the extra domain-containing form of cellular fibronectin in human placentas at different stages of maturation. Histochemistry 90:25-30[Medline]

Virtanen I, Lehto V-P, Lehtonen E, Vartio T, Stenman S, Kurki P, Wager O, Small JV, Dahl D, Badley RA (1981) Expression of intermediate filaments in cultured cells. J Cell Sci 50:45-63[Medline]

Virtanen I, Lohi J, Tani T, Korhonen M, Burgeson RE, Lehto V-P, Leivo I (1997) Distinct changes in the laminin composition of basement membranes in human seminiferous tubules during development and degeneration. Am J Pathol 150:1421-1431[Abstract]

Wewer U, Albrechtsen R, Manthorpe M, Varon S, Engvall E, Ruoslahti E (1983) Human laminin isolated in a nearly intact, biologically active form from placenta by limited proteolysis. J Biol Chem 258:12654-12660[Abstract/Free Full Text]

Yamada T, Isemura M, Yamaguchi Y, Munakata H, Hayashi N, Kyogoku M (1987) Immunohistochemical localization of fibronectin in the human placentas at their different stages of maturation. Histochemistry 86:579-584[Medline]

Yamaguchi Y, Isemura M, Yosizawa Z, Kurosawa K, Yoshinaga K, Sato A, Suzuki M (1985) Changes in the distribution of fibronectin in the placenta during normal human pregnancy. Am J Obstet Gynecol 152:715-718[Medline]